With an increasing number of similar GLP-1 drugs now being used in clinical practice, for conditions ranging from type 2 diabetes and obesity to kidney disease, our findings highlight the potential for these existing drugs to be repurposed to treat the risk of no-reflow in heart attack patients, offering a potentially life-saving solution, said University College London Professor David Atwell
Prep Your Supplies : Wash hands and gather the Lipo C Complex vial, insulin syringe, alcohol swabs, and a sharps container
Reducing heart disease risk by preventing oxidative damage Oxidative damage to heart tissues is a common precursor to heart disease, potentially leading to stroke, heart attack, and other severe conditions
They can help determine the underlying cause and recommend ways to relieve symptoms
doi: 10.1089/thy.2012.0579 12